UNSPSC 51131506: Erythropoietin

This classification denotes a chemotherapy regimen used to treat non-hodgkins lymphoma with the molecular formula C809H1301N229O240S5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64FS3BFH5W, more generally known as erythropoietin. European Medicines Agency schedules erythropoietin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06575MIG. The term ERYTHROPOIETIN is an International Non-Proprietary Name or INN. As of Q4 2014, ERYTHROPOIETIN remains the US FDA Preferred Term for this commodity.

Erythropoietin bears US NLM identifiers UMLS ID C0014822 and NCI Concept Code C20429. SMILES: NONE.

UNSPSC 51131506 Erythropoietin is a Commodity code that nominally covers a specific pharmaceutical product used to treat anemia and related blood disorders. However, the recent state and local contracting activity under this code shows no alignment with the pharmaceutical scope—the single identified opportunity is a law enforcement equipment RFP issued by Sourcewell, a Minnesota local government cooperative, with no connection to erythropoietin procurement. State and local governments do not appear to be actively sourcing erythropoietin as a standalone commodity through open market procurements; procurement of this medication typically flows through healthcare systems, pharmacy benefit managers, or federal health programs using different code families or vendor arrangements.

Sourcewell (a State of Minnesota local government unit and service cooperative) posted RFP #061626 on May 12, 2026, with a response deadline of June 16, 2026 at 3:30 p.m. Central Time, seeking law enforcement equipment for use by participating jurisdictions including Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County in Washington, along with other public entities across the United States and Canada. The solicitation establishes a cooperative purchasing vehicle open to governmental agencies, higher education institutions, school districts, nonprofit organizations, and tribal governments. This opportunity carries no stated budget, set-aside designation, or incumbent vendor information. The mismatch between the code's pharmaceutical definition and the actual law enforcement equipment procurement suggests either a coding error in the state and local system or dormant activity under this code—vendors pursuing erythropoietin sales to state and local health departments, correctional systems, or public hospitals should verify current activity through direct agency outreach rather than relying on recent RFP visibility.